FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110854077> ?p ?o ?g. }

• W2110854077 endingPage "300" @default.
• W2110854077 startingPage "291" @default.
• W2110854077 abstract "Objective. To assess current Dutch antithrombotic treatment strategies for acute coronary syndrome (ACS) in light of the current European Society of Cardiology (ESC) guidelines. Methods. For every Dutch hospital with a coronary care unit (CCU) (n = 93) a single cardiologist was interviewed concerning heparin, thienopyridine and GP IIb/IIIa inhibitor (GPI) treatment. In each hospital, we randomly approached one cardiologist assuming equal policy among physicians employed at the same hospital. Results. The response rate was 90%. In 59% of hospitals, treatment of ST-elevation myocardial infarction (STEMI) occurred according to the 2008 ESC STEMI guideline, with unfractionated heparin. In contrast, although not recommended, low-molecular-weight heparin (LMWH) was used in 39% (enoxaparin 19%, dalteparin 12%, nadroparin 8%). In non-STEMI, low-molecular-weight-heparins (LMWHs) were used in 97% of all hospitals. Fondaparinux, agent of choice in a noninvasive strategy for the treatment of non-STEMI, was applied in only 2% of hospitals. Although recommended by the ESC, dose adjustment of LMWH therapy for patients with renal failure is not applied in 71% of hospitals. Likewise, LMWH dose adjustment is not applied for patients aged over 75 years in 92% of hospitals. Conclusion. To a great extent treatment of ACS in the Netherlands occurs according to ESC guidelines. Additional benefit may be achieved by routine dose adjustment of LMWH for patients with renal insufficiency and aged >75 years, since these patients are at high risk of bleeding complications secondary to antithrombotic treatment. Periodical evaluation of real-life practice may improve guideline adherence and potentially improve clinical outcome. (Neth Heart J 2010;18:291-9.)" @default.
• W2110854077 created "2016-06-24" @default.
• W2110854077 creator A5006701743 @default.
• W2110854077 creator A5045751456 @default.
• W2110854077 creator A5047779930 @default.
• W2110854077 creator A5054452062 @default.
• W2110854077 creator A5065566368 @default.
• W2110854077 date "2010-06-01" @default.
• W2110854077 modified "2023-09-25" @default.
• W2110854077 title "Guideline adherence for antithrombotic therapy in acute coronary syndrome: an overview in Dutch hospitals" @default.
• W2110854077 cites W153597901 @default.
• W2110854077 cites W184399110 @default.
• W2110854077 cites W1988415842 @default.
• W2110854077 cites W2001554000 @default.
• W2110854077 cites W2004919488 @default.
• W2110854077 cites W2011007155 @default.
• W2110854077 cites W2036263484 @default.
• W2110854077 cites W2042404064 @default.
• W2110854077 cites W2059393429 @default.
• W2110854077 cites W2085413583 @default.
• W2110854077 cites W2088568229 @default.
• W2110854077 cites W2106528571 @default.
• W2110854077 cites W2111969206 @default.
• W2110854077 cites W2117254307 @default.
• W2110854077 cites W2120309051 @default.
• W2110854077 cites W2131370832 @default.
• W2110854077 cites W2134124835 @default.
• W2110854077 cites W2136351044 @default.
• W2110854077 cites W2139834809 @default.
• W2110854077 cites W2144692950 @default.
• W2110854077 cites W2152893708 @default.
• W2110854077 cites W2156927593 @default.
• W2110854077 cites W2568050971 @default.
• W2110854077 cites W2616526627 @default.
• W2110854077 cites W3162269940 @default.
• W2110854077 cites W70145905 @default.
• W2110854077 cites W74963018 @default.
• W2110854077 doi "https://doi.org/10.1007/bf03091779" @default.
• W2110854077 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2881345" @default.
• W2110854077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20657674" @default.
• W2110854077 hasPublicationYear "2010" @default.
• W2110854077 type Work @default.
• W2110854077 sameAs 2110854077 @default.
• W2110854077 citedByCount "6" @default.
• W2110854077 countsByYear W21108540772012 @default.
• W2110854077 countsByYear W21108540772013 @default.
• W2110854077 countsByYear W21108540772015 @default.
• W2110854077 crossrefType "journal-article" @default.
• W2110854077 hasAuthorship W2110854077A5006701743 @default.
• W2110854077 hasAuthorship W2110854077A5045751456 @default.
• W2110854077 hasAuthorship W2110854077A5047779930 @default.
• W2110854077 hasAuthorship W2110854077A5054452062 @default.
• W2110854077 hasAuthorship W2110854077A5065566368 @default.
• W2110854077 hasBestOaLocation W21108540772 @default.
• W2110854077 hasConcept C126322002 @default.
• W2110854077 hasConcept C142724271 @default.
• W2110854077 hasConcept C164705383 @default.
• W2110854077 hasConcept C177713679 @default.
• W2110854077 hasConcept C194828623 @default.
• W2110854077 hasConcept C2776877702 @default.
• W2110854077 hasConcept C2776884760 @default.
• W2110854077 hasConcept C2777015399 @default.
• W2110854077 hasConcept C2777260377 @default.
• W2110854077 hasConcept C2777557582 @default.
• W2110854077 hasConcept C2777698277 @default.
• W2110854077 hasConcept C2780182762 @default.
• W2110854077 hasConcept C2780400711 @default.
• W2110854077 hasConcept C2780868729 @default.
• W2110854077 hasConcept C2991741193 @default.
• W2110854077 hasConcept C500558357 @default.
• W2110854077 hasConcept C71924100 @default.
• W2110854077 hasConceptScore W2110854077C126322002 @default.
• W2110854077 hasConceptScore W2110854077C142724271 @default.
• W2110854077 hasConceptScore W2110854077C164705383 @default.
• W2110854077 hasConceptScore W2110854077C177713679 @default.
• W2110854077 hasConceptScore W2110854077C194828623 @default.
• W2110854077 hasConceptScore W2110854077C2776877702 @default.
• W2110854077 hasConceptScore W2110854077C2776884760 @default.
• W2110854077 hasConceptScore W2110854077C2777015399 @default.
• W2110854077 hasConceptScore W2110854077C2777260377 @default.
• W2110854077 hasConceptScore W2110854077C2777557582 @default.
• W2110854077 hasConceptScore W2110854077C2777698277 @default.
• W2110854077 hasConceptScore W2110854077C2780182762 @default.
• W2110854077 hasConceptScore W2110854077C2780400711 @default.
• W2110854077 hasConceptScore W2110854077C2780868729 @default.
• W2110854077 hasConceptScore W2110854077C2991741193 @default.
• W2110854077 hasConceptScore W2110854077C500558357 @default.
• W2110854077 hasConceptScore W2110854077C71924100 @default.
• W2110854077 hasIssue "6" @default.
• W2110854077 hasLocation W21108540771 @default.
• W2110854077 hasLocation W21108540772 @default.
• W2110854077 hasLocation W21108540773 @default.
• W2110854077 hasLocation W21108540774 @default.
• W2110854077 hasOpenAccess W2110854077 @default.
• W2110854077 hasPrimaryLocation W21108540771 @default.
• W2110854077 hasRelatedWork W1443617441 @default.
• W2110854077 hasRelatedWork W150076744 @default.
• W2110854077 hasRelatedWork W2036208315 @default.

• next